The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Atrial Septal Occluder Market Research Report 2025
Synopsis
An atrial septal occluder is a medical device used to close an atrial septal defect (ASD), which is a hole in the wall (septum) that separates the two upper chambers (atria) of the heart. This device is a treatment option for individuals with ASD who require closure to prevent blood flow between the atria and improve heart function.
Global Atrial Septal Occluder market is projected to reach US$ 1283.6 million in 2029, increasing from US$ 930 million in 2022, with the CAGR of 4.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Atrial Septal Occluder market research.
The global atrial septal occluder market refers to the market for devices used in the closure of atrial septal defects (ASDs), which are congenital heart defects involving a hole in the wall (septum) separating the two upper chambers of the heart (atria). Atrial septal occluders are implantable devices designed to close these holes and restore normal blood flow within the heart.
The market for atrial septal occluders is driven by several factors. Firstly, the rising prevalence of ASDs globally contributes to the demand for effective closure devices. Improved diagnostics techniques and increased awareness of congenital heart defects have led to earlier identification and intervention, allowing for better management of ASDs.
Secondly, advancements in medical technologies and surgical techniques have significantly improved the treatment and outcomes for individuals with ASDs. Atrial septal occluders provide a minimally invasive alternative to traditional open-heart surgeries, resulting in shorter hospital stays, faster recovery times, and reduced overall healthcare costs. These factors have contributed to the increasing adoption of atrial septal occluders as the preferred treatment option for ASD closure.
Furthermore, the growing focus on patient-centric approaches and personalized medicine has led to the development of innovative and improved atrial septal occluder designs. These devices offer better procedural outcomes, reduced risk of complications, and enhanced patient comfort. Additionally, ongoing research is focused on optimizing device size, improving closure efficacy, and reducing long-term complications associated with atrial septal occluders.
Geographically, North America, Europe, and Asia-Pacific are the prominent markets for atrial septal occluders. These regions have well-established healthcare systems, advanced cardiac care facilities, and higher prevalence of ASD cases. Increased access to healthcare services, favorable reimbursement policies, and the presence of key market players contribute to the overall market growth.
Key players in the global atrial septal occluder market include medical device manufacturers, interventional cardiology companies, and healthcare providers. These companies are engaged in the development, manufacturing, and commercialization of atrial septal occluders, as well as providing procedural training and support to healthcare professionals.
In conclusion, the global atrial septal occluder market is driven by the rising prevalence of ASDs, advancements in medical technologies and surgical techniques, and the growing focus on patient-centered approaches. Atrial septal occluders offer a minimally invasive treatment option with improved procedural outcomes, reduced complications, and faster recovery times. With the increasing adoption of atrial septal occluders as the preferred treatment choice, the market is expected to witness significant growth in the coming years.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Atrial Septal Occluder market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Abbott Laboratories
Medtronic Plc
Endologix Inc
LivaNova Plc
CryoLife Inc
Cook Group Incorporated
Edwards Lifesciences Corporation
W. L. Gore & Associates
Lepu Medical Technology
CeraFlex
Segment by Type
Atrial Septal Defect Device
Ventricular Septal Defect Device
Segment by Application
Hospital
Outpatient Surgery Center
Specialty Clinics
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Atrial Septal Occluder report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
An atrial septal occluder is a medical device used to close an atrial septal defect (ASD), which is a hole in the wall (septum) that separates the two upper chambers (atria) of the heart. This device is a treatment option for individuals with ASD who require closure to prevent blood flow between the atria and improve heart function.
Global Atrial Septal Occluder market is projected to reach US$ 1283.6 million in 2029, increasing from US$ 930 million in 2022, with the CAGR of 4.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Atrial Septal Occluder market research.
The global atrial septal occluder market refers to the market for devices used in the closure of atrial septal defects (ASDs), which are congenital heart defects involving a hole in the wall (septum) separating the two upper chambers of the heart (atria). Atrial septal occluders are implantable devices designed to close these holes and restore normal blood flow within the heart.
The market for atrial septal occluders is driven by several factors. Firstly, the rising prevalence of ASDs globally contributes to the demand for effective closure devices. Improved diagnostics techniques and increased awareness of congenital heart defects have led to earlier identification and intervention, allowing for better management of ASDs.
Secondly, advancements in medical technologies and surgical techniques have significantly improved the treatment and outcomes for individuals with ASDs. Atrial septal occluders provide a minimally invasive alternative to traditional open-heart surgeries, resulting in shorter hospital stays, faster recovery times, and reduced overall healthcare costs. These factors have contributed to the increasing adoption of atrial septal occluders as the preferred treatment option for ASD closure.
Furthermore, the growing focus on patient-centric approaches and personalized medicine has led to the development of innovative and improved atrial septal occluder designs. These devices offer better procedural outcomes, reduced risk of complications, and enhanced patient comfort. Additionally, ongoing research is focused on optimizing device size, improving closure efficacy, and reducing long-term complications associated with atrial septal occluders.
Geographically, North America, Europe, and Asia-Pacific are the prominent markets for atrial septal occluders. These regions have well-established healthcare systems, advanced cardiac care facilities, and higher prevalence of ASD cases. Increased access to healthcare services, favorable reimbursement policies, and the presence of key market players contribute to the overall market growth.
Key players in the global atrial septal occluder market include medical device manufacturers, interventional cardiology companies, and healthcare providers. These companies are engaged in the development, manufacturing, and commercialization of atrial septal occluders, as well as providing procedural training and support to healthcare professionals.
In conclusion, the global atrial septal occluder market is driven by the rising prevalence of ASDs, advancements in medical technologies and surgical techniques, and the growing focus on patient-centered approaches. Atrial septal occluders offer a minimally invasive treatment option with improved procedural outcomes, reduced complications, and faster recovery times. With the increasing adoption of atrial septal occluders as the preferred treatment choice, the market is expected to witness significant growth in the coming years.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Atrial Septal Occluder market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Abbott Laboratories
Medtronic Plc
Endologix Inc
LivaNova Plc
CryoLife Inc
Cook Group Incorporated
Edwards Lifesciences Corporation
W. L. Gore & Associates
Lepu Medical Technology
CeraFlex
Segment by Type
Atrial Septal Defect Device
Ventricular Septal Defect Device
Segment by Application
Hospital
Outpatient Surgery Center
Specialty Clinics
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Atrial Septal Occluder report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Atrial Septal Occluder Market Overview
1.1 Product Overview and Scope of Atrial Septal Occluder
1.2 Atrial Septal Occluder Segment by Type
1.2.1 Global Atrial Septal Occluder Market Value Comparison by Type (2023-2029)
1.2.2 Atrial Septal Defect Device
1.2.3 Ventricular Septal Defect Device
1.3 Atrial Septal Occluder Segment by Application
1.3.1 Global Atrial Septal Occluder Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Outpatient Surgery Center
1.3.4 Specialty Clinics
1.4 Global Atrial Septal Occluder Market Size Estimates and Forecasts
1.4.1 Global Atrial Septal Occluder Revenue 2018-2029
1.4.2 Global Atrial Septal Occluder Sales 2018-2029
1.4.3 Global Atrial Septal Occluder Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Atrial Septal Occluder Market Competition by Manufacturers
2.1 Global Atrial Septal Occluder Sales Market Share by Manufacturers (2018-2023)
2.2 Global Atrial Septal Occluder Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Atrial Septal Occluder Average Price by Manufacturers (2018-2023)
2.4 Global Atrial Septal Occluder Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Atrial Septal Occluder, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Atrial Septal Occluder, Product Type & Application
2.7 Atrial Septal Occluder Market Competitive Situation and Trends
2.7.1 Atrial Septal Occluder Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Atrial Septal Occluder Players Market Share by Revenue
2.7.3 Global Atrial Septal Occluder Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Atrial Septal Occluder Retrospective Market Scenario by Region
3.1 Global Atrial Septal Occluder Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Atrial Septal Occluder Global Atrial Septal Occluder Sales by Region: 2018-2029
3.2.1 Global Atrial Septal Occluder Sales by Region: 2018-2023
3.2.2 Global Atrial Septal Occluder Sales by Region: 2024-2029
3.3 Global Atrial Septal Occluder Global Atrial Septal Occluder Revenue by Region: 2018-2029
3.3.1 Global Atrial Septal Occluder Revenue by Region: 2018-2023
3.3.2 Global Atrial Septal Occluder Revenue by Region: 2024-2029
3.4 North America Atrial Septal Occluder Market Facts & Figures by Country
3.4.1 North America Atrial Septal Occluder Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Atrial Septal Occluder Sales by Country (2018-2029)
3.4.3 North America Atrial Septal Occluder Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Atrial Septal Occluder Market Facts & Figures by Country
3.5.1 Europe Atrial Septal Occluder Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Atrial Septal Occluder Sales by Country (2018-2029)
3.5.3 Europe Atrial Septal Occluder Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Atrial Septal Occluder Market Facts & Figures by Country
3.6.1 Asia Pacific Atrial Septal Occluder Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Atrial Septal Occluder Sales by Country (2018-2029)
3.6.3 Asia Pacific Atrial Septal Occluder Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Atrial Septal Occluder Market Facts & Figures by Country
3.7.1 Latin America Atrial Septal Occluder Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Atrial Septal Occluder Sales by Country (2018-2029)
3.7.3 Latin America Atrial Septal Occluder Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Atrial Septal Occluder Market Facts & Figures by Country
3.8.1 Middle East and Africa Atrial Septal Occluder Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Atrial Septal Occluder Sales by Country (2018-2029)
3.8.3 Middle East and Africa Atrial Septal Occluder Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Atrial Septal Occluder Sales by Type (2018-2029)
4.1.1 Global Atrial Septal Occluder Sales by Type (2018-2023)
4.1.2 Global Atrial Septal Occluder Sales by Type (2024-2029)
4.1.3 Global Atrial Septal Occluder Sales Market Share by Type (2018-2029)
4.2 Global Atrial Septal Occluder Revenue by Type (2018-2029)
4.2.1 Global Atrial Septal Occluder Revenue by Type (2018-2023)
4.2.2 Global Atrial Septal Occluder Revenue by Type (2024-2029)
4.2.3 Global Atrial Septal Occluder Revenue Market Share by Type (2018-2029)
4.3 Global Atrial Septal Occluder Price by Type (2018-2029)
5 Segment by Application
5.1 Global Atrial Septal Occluder Sales by Application (2018-2029)
5.1.1 Global Atrial Septal Occluder Sales by Application (2018-2023)
5.1.2 Global Atrial Septal Occluder Sales by Application (2024-2029)
5.1.3 Global Atrial Septal Occluder Sales Market Share by Application (2018-2029)
5.2 Global Atrial Septal Occluder Revenue by Application (2018-2029)
5.2.1 Global Atrial Septal Occluder Revenue by Application (2018-2023)
5.2.2 Global Atrial Septal Occluder Revenue by Application (2024-2029)
5.2.3 Global Atrial Septal Occluder Revenue Market Share by Application (2018-2029)
5.3 Global Atrial Septal Occluder Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Abbott Laboratories
6.1.1 Abbott Laboratories Corporation Information
6.1.2 Abbott Laboratories Description and Business Overview
6.1.3 Abbott Laboratories Atrial Septal Occluder Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Abbott Laboratories Atrial Septal Occluder Product Portfolio
6.1.5 Abbott Laboratories Recent Developments/Updates
6.2 Medtronic Plc
6.2.1 Medtronic Plc Corporation Information
6.2.2 Medtronic Plc Description and Business Overview
6.2.3 Medtronic Plc Atrial Septal Occluder Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Medtronic Plc Atrial Septal Occluder Product Portfolio
6.2.5 Medtronic Plc Recent Developments/Updates
6.3 Endologix Inc
6.3.1 Endologix Inc Corporation Information
6.3.2 Endologix Inc Description and Business Overview
6.3.3 Endologix Inc Atrial Septal Occluder Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Endologix Inc Atrial Septal Occluder Product Portfolio
6.3.5 Endologix Inc Recent Developments/Updates
6.4 LivaNova Plc
6.4.1 LivaNova Plc Corporation Information
6.4.2 LivaNova Plc Description and Business Overview
6.4.3 LivaNova Plc Atrial Septal Occluder Sales, Revenue and Gross Margin (2018-2023)
6.4.4 LivaNova Plc Atrial Septal Occluder Product Portfolio
6.4.5 LivaNova Plc Recent Developments/Updates
6.5 CryoLife Inc
6.5.1 CryoLife Inc Corporation Information
6.5.2 CryoLife Inc Description and Business Overview
6.5.3 CryoLife Inc Atrial Septal Occluder Sales, Revenue and Gross Margin (2018-2023)
6.5.4 CryoLife Inc Atrial Septal Occluder Product Portfolio
6.5.5 CryoLife Inc Recent Developments/Updates
6.6 Cook Group Incorporated
6.6.1 Cook Group Incorporated Corporation Information
6.6.2 Cook Group Incorporated Description and Business Overview
6.6.3 Cook Group Incorporated Atrial Septal Occluder Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Cook Group Incorporated Atrial Septal Occluder Product Portfolio
6.6.5 Cook Group Incorporated Recent Developments/Updates
6.7 Edwards Lifesciences Corporation
6.6.1 Edwards Lifesciences Corporation Corporation Information
6.6.2 Edwards Lifesciences Corporation Description and Business Overview
6.6.3 Edwards Lifesciences Corporation Atrial Septal Occluder Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Edwards Lifesciences Corporation Atrial Septal Occluder Product Portfolio
6.7.5 Edwards Lifesciences Corporation Recent Developments/Updates
6.8 W. L. Gore & Associates
6.8.1 W. L. Gore & Associates Corporation Information
6.8.2 W. L. Gore & Associates Description and Business Overview
6.8.3 W. L. Gore & Associates Atrial Septal Occluder Sales, Revenue and Gross Margin (2018-2023)
6.8.4 W. L. Gore & Associates Atrial Septal Occluder Product Portfolio
6.8.5 W. L. Gore & Associates Recent Developments/Updates
6.9 Lepu Medical Technology
6.9.1 Lepu Medical Technology Corporation Information
6.9.2 Lepu Medical Technology Description and Business Overview
6.9.3 Lepu Medical Technology Atrial Septal Occluder Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Lepu Medical Technology Atrial Septal Occluder Product Portfolio
6.9.5 Lepu Medical Technology Recent Developments/Updates
6.10 CeraFlex
6.10.1 CeraFlex Corporation Information
6.10.2 CeraFlex Description and Business Overview
6.10.3 CeraFlex Atrial Septal Occluder Sales, Revenue and Gross Margin (2018-2023)
6.10.4 CeraFlex Atrial Septal Occluder Product Portfolio
6.10.5 CeraFlex Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Atrial Septal Occluder Industry Chain Analysis
7.2 Atrial Septal Occluder Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Atrial Septal Occluder Production Mode & Process
7.4 Atrial Septal Occluder Sales and Marketing
7.4.1 Atrial Septal Occluder Sales Channels
7.4.2 Atrial Septal Occluder Distributors
7.5 Atrial Septal Occluder Customers
8 Atrial Septal Occluder Market Dynamics
8.1 Atrial Septal Occluder Industry Trends
8.2 Atrial Septal Occluder Market Drivers
8.3 Atrial Septal Occluder Market Challenges
8.4 Atrial Septal Occluder Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
